Matt Call

Matt Call serves as Chief Operating Officer at iTeos Therapeutics. iTeos Therapeutics operates in the research sector with approximately 200.0 employees. The company is headquartered in Provo, Utah. iTeos Therapeutics generates annual revenue of 35000000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 1,526 executive contacts are available in Utah.
• • Our database includes 201,469 c suite-level executives.

Outlook Mobile Friendly Google Analytics WordPress.org Google Tag Manager reCAPTCHA Remote AI

small molecule immunomodulators immunotherapy drug discovery biotechnology: biological products (no diagnostic substances) health care biotechnology research cancer therapy biopharmaceuticals clinical trials anti-tigit a2a receptor antagonist tumor microenvironment immuno-oncology drug development oncology treatments therapeutic candidates immunosuppression novel therapeutics clinical-stage biotech drug combinations pipeline management responsible biopharma scientific collaboration regulatory clearance investor relations biotech innovations cancer indications patient-centric environmental governance social responsibility esg principles immunomodulators tumor immune response therapeutic efficacy biologic rationale high affinity antibodies adaptive immune response intra-portfolio combinations next-generation therapies environmental stewardship clinical outcomes patient survival oncology pipelines targeted therapies adaptive trial designs research collaborations scientific advisory board drug candidates biologics development preclinical research innovation in therapeutics clinical milestones healthcare investors biotech leadership dostarlimab combinations biopharmaceutical clinical-stage cancer therapeutics targeted immunotherapies immunosuppressive pathways immune response novel therapies breakthrough treatments eos-448 belrestotug eos-984 small molecules immune checkpoints t-cell activation cancer treatment oncology market scientific innovation collaboration environmental social governance (esg) strategic partnerships patient outcomes healthcare providers research institutions pharmaceutical partners cancer patients therapeutic development market expansion competitive landscape biotechnology health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Matt Call?

Matt Call's verified email address is available on MessageCEO. They currently work at iTeos Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Matt Call lead?

Matt Call is Chief Operating Officer at iTeos Therapeutics, a company in the research sector with 200.0 employees. The company is based in Provo, Utah.

What industry is Matt Call in?

Matt Call works in the research industry as Chief Operating Officer at iTeos Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Matt Call's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Matt Call's profile is kept up-to-date with the latest available information.

Last updated: April 8, 2026